Economic Burden of Alopecia Areata in the Kingdom of Saudi Arabia from a Societal Perspective: A Cost-of-Illness Analysis

    Khalidah A. Alenzi, Abdulrahman Alturaiki, Mohammad I. Fatani, Saad Alsogair, Ahmed Saeed, Ayman Behiry, Ali Almomatin
    TLDR Alopecia areata in Saudi Arabia is costly, mainly due to lost productivity and drug costs.
    Alopecia areata (AA) in Saudi Arabia presents a significant economic burden, with costs driven primarily by productivity losses and drug acquisition. The study found that the average annual per-patient cost is SAR 20,703 for mild to moderate AA and SAR 76,957 for severe AA, leading to a total burden of SAR 5.827 billion and SAR 3.352 billion, respectively. Refractory cases incur even higher costs over 2 years. The findings highlight the importance of early diagnosis, standardized treatment, and access to innovative therapies to reduce the financial impact. Implementing integrated care pathways and national registries could optimize resource allocation and improve patient outcomes.
    Discuss this study in the Community →

    Research cited in this study

    23 / 23 results

    Related Community Posts Join

    6 / 1000+ results

    Similar Research

    5 / 1000+ results